The U.S. Zilbrysq (Zilucoplan) market size was estimated at USD 60.61 million in 2024 and is projected to grow at a CAGR of 21.64% from 2025 to 2030. The U.S. Zilbrysq (Zilucoplan) industry is witnessing robust growth following its FDA approval in October 2023 for the treatment of anti-A... Read More »
June 2025The global zilbrysq (zilucoplan) market size was estimated at USD 77.92 million in 2024 and is projected to reach USD 679.58 million by 2030, growing at a CAGR of 28.39% from 2025 to 2030. The market is experiencing significant growth, driven by its regulatory approvals in key markets su... Read More »
June 2025The U.S. enteral feeding formulas market size was estimated at USD 2.06 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2030. The increasing prevalence of chronic diseases, including cancer, stroke, multiple sclerosis, dementia, chronic liver disease, chronic obst... Read More »
June 2025The global Vyvgart (Efgartigimod) market size was estimated at USD 2.19 billion in 2024 and is projected to reach USD 5.50 billion by 2030, growing at a CAGR of 13.6% from 2025 to 2030. The market is experiencing significant growth, driven by several key factors. The increasing prevalenc... Read More »
June 2025The global alopecia market size was estimated at USD 9.48 billion in 2024 and is projected to reach USD 16.02 billion by 2030, growing at a CAGR of 8.7% from 2025 to 2030. One of the major driving factors for the market is the increasing awareness regarding alopecia treatment options, as... Read More »
June 2025The global hemophilia market size was estimated at USD 14.11 billion in 2024 and is projected to reach USD 21.07 billion by 2030, growing at a CAGR of 6.91% from 2025 to 2030. The major factor driving the market is gene therapy approval, and multiple other candidates in various pipeline ... Read More »
June 2025The global multiple sclerosis therapeutic market size was estimated at USD 27.39 billion in 2024 and is projected to reach USD 38.62 billion by 2030, growing at a CAGR of 5.93% from 2025 to 2030. The market growth is due to the rise in the global prevalence of the disease, and the advanc... Read More »
June 2025The Europe pharmaceutical market size was estimated at USD 488.05 billion in 2024 and is projected to grow at a CAGR of 5.90% from 2025 to 2030. Several factors, including an aging population, advancements in medical technology, and rising healthcare spending, drive market growth. In add... Read More »
June 2025The U.S. inflammatory bowel disease treatment market size was estimated at USD 13.12 billion in 2024 and is projected to grow at a CAGR of 2.7% from 2025 to 2030. The market is driven by the rising adoption of advanced therapeutic options such as biologics, JAK inhibitors, and personaliz... Read More »
June 2025The India GLP-1 receptor agonist market size was estimated at USD 110.55 million in 2024 and is projected to grow at a CAGR of 34.3% from 2025 to 2030. The market is driven by the rising incidence of chronic conditions such as type 2 diabetes and obesity, increasing R&D activities fo... Read More »
June 2025The global ultomiris drug market size was estimated at USD 3.92 billion in 2024 and is projected to reach USD 18.03 billion by 2030, growing at a CAGR of 28.47% from 2025 to 2030. The global Ultomiris (ravulizumab) drug industry is experiencing strong momentum due to the rising demand fo... Read More »
May 2025The global respiratory disease vaccine market size was estimated at USD 92.23 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 1.21% from 2023 to 2030. The market is witnessing growth due to factors such as the rising prevalence of respiratory diseases, ... Read More »
May 2025The global hair thinning market size was estimated at USD 1.51 billion in 2024 and is projected to reach USD 2.75 billion by 2030, growing at a CAGR 10.85% from 2025 to 2030. The increasing awareness about hair wellness, the growing risk of alopecia & other hair-related problems... Read More »
May 2025The global oral clinical nutrition market size was estimated at USD 17.16 billion in 2024 and is projected to reach USD 22.97 billion by 2030, growing at a CAGR of 5.0% from 2025 to 2030. The growing rates of malnutrition in adults, along with increasing cases of obesity and chronic cond... Read More »
May 2025The global perjeta market size was estimated at USD 4.30 billion in 2024 and is projected to grow at a CAGR of 5.5% from 2025 to 2030, driven by the increasing prevalence of HER2-positive breast cancer worldwide. Early detection and enhanced diagnostics have increased the identification ... Read More »
May 2025The global antifungal drugs market size was estimated at USD 16.34 billion in 2024 and is projected to reach USD 20.52 billion by 2030, growing at a CAGR of 3.92% from 2025 to 2030. The rising incidence of fungal infections, including aspergillosis and candidiasis, continues to driv... Read More »
May 2025The global polycystic ovarian syndrome treatment market size was estimated at USD 4.79 billion in 2024 and is projected to grow at a CAGR of 6.6% from 2025 to 2030. The growth rate is attributed to lifestyle changes, indulgence in alcohol, rising incidences of depression and stress, and ... Read More »
May 2025The global local anesthesia drugs market size was valued at USD 4.14 billion in 2024 and is projected to reach USD 5.13 billion by 2030, growing at a CAGR of 3.70% from 2025 to 2030... Read More »
May 2025The global intravenous iron drugs market size was estimated at USD 3,302.1 million in 2024 and is projected to reach USD 5,578.2 million by 2030, growing at a CAGR of 9.1% from 2025 to 2030. One of the major factors for market growth is the increasing prevalence of chronic kidney di... Read More »
May 2025The global remicade market size was estimated at USD 3.04 billion in 2024 and is projected to decline at a CAGR of -2.28% from 2025 to 2030, primarily due to the rise of cost-effective biosimilars following patent expirations and growing preference for newer biologic therapies. While rem... Read More »
May 2025